Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (FOR2886 PANDORA, CRC1181 Checkpoints for Resolution of Inflammation)
Bundesministerium für Bildung und Forschung (MASCARA)
Innovative Medicines Initiative (RTCure)
Friedrich-Alexander-Universität Erlangen-Nürnberg (Emerging Fields Initiative MIRACLE)
Else Kröner-Fresenius-Stiftung (Memorial Scholarship (No. 2019_EKMS.27))
ERC Synergy grant (4D Nanoscope)
Received: 13 April 2020
Accepted: 10 February 2021
First Online: 27 February 2021
Ethics approval and consent to participate
: The study was approved by the Ethics Committee of the Friedrich-Alexander University of Erlangen-Nuremberg, Germany (approval number Az:01_2010) and all local ethics committees of the external centers as well as the Paul-Ehrlich Institute; the study was conducted according to the ethical principles of the Declaration of Helsinki. Patients’ written informed consent was obtained.
: Not applicable
: None to declare.